The University of Chicago's Michael P. Polsky Center for Entrepreneurship at Chicago Booth and the Office of Technology and Intellectual Property (UChicagoTech) have teamed up to present a new innovation workshop series for University researchers, innovators, friends, entrepreneurs and investors to educate, network, and facilitate the best practices for commercializing University technology and invention. The series is sponsored by ARCH Venture Partners, a leader in the successful commercialization of technologies developed at academic research institutions and national laboratories.
The first program in the ARCH Venture Partners Innovation Workshop Series will feature Steve Lazarus, co-founder and managing director of ARCH Venture Partners, who will give a presentation titled "Discovery Matters." Maryellen Giger, Professor in Radiology and Committee on Medical Physics, will join Lazarus during the Q&A to share her personal involvement in the founding of R2 Technologies. The free event, held on Thursday, May 7, from 5 until 7 p.m., at the University of Chicago Quadrangle Club, Second Floor Library, Solarium, 1155 East 57th St., Chicago, will be followed by a reception with refreshments.
Before founding ARCH Venture Partners, Lazarus served as CEO of ARCH Development Corporation (a precursor to UChicagoTech) and as Associate Dean of the University of Chicago Booth School of Business. He previously spent 13 years with Baxter Laboratories in various senior roles, most recently as Group Vice President of the Health Care Services Group of Baxter Travenol Laboratories. Lazarus also served in Washington D.C., as Deputy Assistant Secretary of Commerce for East-West Trade for the U.S., a government bureau he both founded and directed. Lazarus is a 21-year veteran of the U.S. Navy, retiring with the rank of Captain in 1973.
Advanced registration for the program is required at http://polskycenter.com/Registration.html.
The series features guest speakers with expertise and special knowledge in topics specific to commercializing innovation including best practices, discovering applications and identifying market potential, building a team and network for advancing innovation, and determining funding options, among others.
ARCH Venture Partners invests primarily in companies co-founded with leading scientists and entrepreneurs, concentrating on bringing to market innovations in life sciences, physical sciences, and information technology.